biotech · Pulmonary Disease, Chronic Obstructive · Symptomatic Neurogenic Orthostatic Hypertension · TBPH
Theravance Biopharma Ireland
Theravance Biopharma Ireland Umited
Theravance Biopharma Ireland patent portfolio — 635 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 901 Gateway Blvd., South San Francisco, CA 94080, US
- Founded
- 2014
- Employees
- 177
- Programs
- 57
- Drugs
- 18
- Patents
- 635
Theravance Biopharma Ireland patents
635 pharmaceutical patents indexed for Theravance Biopharma Ireland. 56 expire within 24 months.
Theravance Biopharma Ireland has 635 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 56 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 6635764
Therapeutic ureas
expired -
US 6620781
Glycopeptide carboxy-saccharide derivatives
expired -
US 6576791
Local anesthetic compounds and uses
expired -
US 6576793
&bgr;2-adrenergic receptor agonists
expired -
US 6566509
Multivalent macrolide antibiotics
expired -
US 6541669
&bgr;2-adrenergic receptor agonists
expired -
US 6518242
Derivatives of glycopeptide antibacterial agents
expired -
US 6495681
Local anesthetic compounds and uses
expired -
US 6479498
Sodium channel drugs and uses
expired -
US 6455669
Glycopeptide derivatives and pharmaceutical compositions containing the same
expired -
US 6436919
Local anesthetic compounds
expired
Frequently asked questions
How many patents does Theravance Biopharma Ireland have?
635 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Theravance Biopharma Ireland patents expire?
56 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.